Bizarre Patents
Cloaking System Using Optoelectronically Controlled Camouflage
A Cloaking System designed to operate in the visible light spectrum, utilizes optoelectronics and/or photonic components to conceal an object within it.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7226622 | Chemoablation of tissue using biodegradable, solid salt dosage forms Novel methods for the chemical ablation of tissue (e.g. prostatic tissue) are described. These methods include the steps of: (a) providing one or more solid salt dosage form comprising 50-100% w/w salt; and (b) inserting one or more of such solid salt dosage forms i... | 06/05/2007 |
| 7175858 | Calcium phosphate cements and methods for using the same Methods and compositions for producing flowable compositions, e.g. pastes, that set into calcium phosphate products are provided. In the subject methods, dry reactants that include a calcium source and a phosphate source are combined with setting fluid to produce th... | 02/13/2007 |
| 7005135 | Glass scaffolds with controlled resorption rates and methods for making same The present invention relates to resorbable glass scaffolds for use in biological applications and methods for making same. Specifically, these scaffolds are composed of phosphate glass fibers, where the rate of dissolution into biological fluids is controlled by th... | 02/28/2006 |
| 6562374 | Biodegradable porous polymer scaffolds for tissue engineering prepared from an effervescent mixture and its preparation The present invention provides a method for preparing biodegradable porous polymer scaffolds for tissue engineering, comprising: a) fabricating a polymer sample from a polymer solution containing at least one biodegradable polymer and an effervescent mixture; ... | 05/13/2003 |
| 6488938 | Polylactic acid scleral plug A scleral plug which releases a drug accurately in a specified amount. The scleral plug is formed from a blend of a high-molecular weight polylactic acid having a molecular weight of 40,000 or higher and a low-molecular weight polylactic acid having a mol... | 12/03/2002 |
| 6291428 | Peptides which promote bone-forming cell attraction and adhesion Peptides are provided with the properties of enhancing the migration and adhesion of bone-forming cells to a substrate, useful for promoting bone mineralization and osseointegration in the healing of, for example, orthopedic surgical procedures.... | 09/18/2001 |
| 6194384 | Long-acting galenical formulation for GRF peptides The present invention relates to a long-acting galenical formulation of GRF peptides, GRF and/or analogs thereof which comprises about 1 to about 100 mg of a GRF peptide, fragment or analog thereof pressed from about 1 to about 100 kg/mm2 in a ... | 02/27/2001 |
| 6074661 | Sterile bioerodible occular implant device with a retinoid for improved biocompatability An implantable device is provided which incorporates a retinoid for improving the biocompatability of the device in eye tissue. The device may be bioerodible for the purpose of systemically or locally releasing a therapeutic agent in tissue or it may be a... | 06/13/2000 |
| 5980928 | Implant for preventing conjunctivitis in cattle A method to reduce the likelihood of conjunctivitis in farm animals, especially cattle, includes the step of injecting an implant containing an antibiotic effective against the microbes associated with conjunctivitis subcutaneously into the animal in clos... | 11/09/1999 |
| 5876721 | Vaccines Vesicles comprising at least one non-ionic surfactant and at least one molecule having the ability to transport or facilitate the transport of fats, fatty acids and lipids across mucosal membranes. With entrapped antigen they can act as immunological adju... | 03/02/1999 |
| 5780051 | Methods and articles of manufacture for nicotine cessation and monitoring nicotine use The present invention features methods and articles of manufacture for treating nicotine withdrawal symptoms and promoting smoking cessation. The methods and articles feature the administration of an effective amount of a nicotine substitute and monitor t... | 07/14/1998 |
| 5549904 | Biological adhesive composition and method of promoting adhesion between tissue surfaces A formulated biological adhesive composition utilizes tissue transglutaminase in a pharmaceutically acceptable aqueous carrier. The tissue transglutaminase is used in an effective catalytic amount to promote adhesion between tissue surfaces upon treatment... | 08/27/1996 |
| 5536503 | Controlled, sustained release delivery system for smoking cessation A drug delivery system useful in aiding individuals in the cessation of smoking or chewing nicotine containing products is described. The delivery system includes a physical constraint modulation system (PCMS™) containing lobeline. The drug delivery sys... | 07/16/1996 |
| 5501856 | Controlled-release pharmaceutical preparation for intra-ocular implant Presented are a controlled-release pharmaceutical preparation for intra-ocular implant to be applied to the interior of the eye after a surgical operation for disorders in retina/vitreous body or for glaucoma, which is produced by homogeneously dispersing... | 03/26/1996 |
| 5486362 | Controlled, sustained release delivery system for treating drug dependency A drug delivery system useful in treating an individual for a drug dependence is described. One embodiment of the system is useful for aiding individuals in the cessation of smoking or chewing nicotine containing products is described. The delivery system... | 01/23/1996 |
| 5422116 | Liquid ophthalmic sustained release delivery system Disclosed is a sustained release liquid aqueous ophthalmic delivery system and a method of providing a slow and sustained release of ophthalmic treating agents to the eye of a mammal which comprises administering to the eye of a said mammal an effective a... | 06/06/1995 |
| 5286490 | Transdermal fluoride medication A transdermal fluoride medication for providing fluoride ion for the prevention and treatment of bone loss disease, which may have an estrogen-containing substance for not only treating hormonal imbalance but to obtain more advantageous use of the fluorid... | 02/15/1994 |
| 5188826 | Topical ophthalmic suspensions A topical, aqueous ophthalmic gel suspension for dry eye is administrable to the eye in drop form, remains as a gel in the eye for a prolonged time, and releases water and one or more ophthalmic demulcents or vasoconstrictors. It comprises water and from ... | 02/23/1993 |
| 5137729 | Drug preparation applicable to oral mucosa A drug preparation applicable to the oral mucosa is disclosed, comprising a soft adhesive film containing a systemic drug, the adhesive film comprising a homogeneous mixture comprising a vinyl acetate homopolymer, an acrylic acid polymer, and a cellulose ... | 08/11/1992 |
| 5128134 | Ophthalmological collagen coverings Ophthalmologic collagen coverings derived from animal eyes and a process for preparing such coverings comprising treatment of a fibrous tunic of an animal eye with an alkali metal hydroxide in a saturated solution of a salt of an alkali metal, followed by... | 07/07/1992 |
| 5094855 | Opthalmological collagen coverings Ophthalmologic collagen coverings derived from animal eyes and a process preparing such coverings comprising treatment of a fibrous tunic of an animal eye with an alkali metal hydroxide in a saturated solution of a salt of an alkali metal, followed by n... | 03/10/1992 |
| 5094856 | Ophthalmological collagen coverings Ophthalmologic collagen coverings derived from animal eyes and a process preparing such coverings comprising treatment of a fibrous tunic of an animal eye with an alkali metal hydroxide in a saturated solution of a salt of an alkali metal, followed by n... | 03/10/1992 |
| 5093127 | Preparation of FR115224 substrate for parenteral administration A cyclic peptide designated FR115224, administered parenterally in a cyclodextrin carrier, which exhibits antiallergic activity.... | 03/03/1992 |
| 5093319 | Use of derivatives of chitin soluble in aqueous solutions for preventing adhesions A method for preventing adhesion between vital tissues includes the step of placing between the tissues a material made up of biodegradable derivatives of chitin which are soluble in aqueous solutions containing dilute acids such as acetic acid. This mate... | 03/03/1992 |
| 4952403 | Implants for the promotion of healing of meniscal tissue Healing of injured avascular tissue is promoted by applying angiogenic factor in proximity to the injured tissue.... | 08/28/1990 |
| 4952404 | Promotion of healing of meniscal tissue Healing of injured avascular tissue is promoted by applying angiogenic factor in proximity to the injured tissue.... | 08/28/1990 |
| 4795536 | Hydrogen separation and electricity generation using novel three-component membrane Apparatus and method for performing an electrochemical process involving hydrogen and gaseous compounds capable of dissociating into or combining with hydrogen ions using a solid electrolyte concentraton cell. Specific applications are fuel cells for prod... | 01/03/1989 |
| 4795436 | Bioadhesive composition and method of treatment therewith A controlled release treatment composition and method of use are disclosed. The composition includes a bioadhesive and an effective amount of a treating agent. The bioadhesive is a water-swellable, but water-insoluble, fibrous, cross-linked carboxy-functi... | 01/03/1989 |
| 4356166 | Time-release chemical delivery system A time-release chemical delivery system in which a bioactive compound is attached to a polymeric biodegradable carrier by a hydrolyzable bond is disclosed. The bioactive compound can either be bound directly to the polymer or be attached to the polymer vi... | 10/26/1982 |
